These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19134476)

  • 1. Multistep aggregation pathway of human interleukin-1 receptor antagonist: kinetic, structural, and morphological characterization.
    Krishnan S; Raibekas AA
    Biophys J; 2009 Jan; 96(1):199-208. PubMed ID: 19134476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High concentration formulations of recombinant human interleukin-1 receptor antagonist: II. Aggregation kinetics.
    Alford JR; Kendrick BS; Carpenter JF; Randolph TW
    J Pharm Sci; 2008 Aug; 97(8):3005-21. PubMed ID: 17924426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biophysical characterization of structural properties and folding of interleukin-1 receptor antagonist.
    Latypov RF; Harvey TS; Liu D; Bondarenko PV; Kohno T; Fachini RA; Rosenfeld RD; Ketchem RR; Brems DN; Raibekas AA
    J Mol Biol; 2007 May; 368(4):1187-201. PubMed ID: 17391700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-protein interactions controlling interfacial aggregation of rhIL-1ra are not described by simple colloid models.
    Sorret LL; DeWinter MA; Schwartz DK; Randolph TW
    Protein Sci; 2018 Jul; 27(7):1191-1204. PubMed ID: 29388282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformation and side chains environments of recombinant human interleukin-1 receptor antagonist (rh-IL-1ra) probed by raman, raman optical activity, and UV-resonance Raman spectroscopy.
    Wen ZQ; Cao X; Vance A
    J Pharm Sci; 2008 Jun; 97(6):2228-41. PubMed ID: 17914732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temperature dependence of benzyl alcohol- and 8-anilinonaphthalene-1-sulfonate-induced aggregation of recombinant human interleukin-1 receptor antagonist.
    Roy S; Katayama D; Dong A; Kerwin BA; Randolph TW; Carpenter JF
    Biochemistry; 2006 Mar; 45(12):3898-911. PubMed ID: 16548517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and thermodynamic effects of ANS binding to human interleukin-1 receptor antagonist.
    Latypov RF; Liu D; Gunasekaran K; Harvey TS; Razinkov VI; Raibekas AA
    Protein Sci; 2008 Apr; 17(4):652-63. PubMed ID: 18305195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population balance modeling of aggregation kinetics of recombinant human interleukin-1 receptor antagonist.
    Chi EY; Kendrick BS; Carpenter JF; Randolph TW
    J Pharm Sci; 2005 Dec; 94(12):2735-48. PubMed ID: 16258998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New structural insights into the refolding of ribonuclease T1 as seen by time-resolved Fourier-transform infrared spectroscopy.
    Reinstädler D; Fabian H; Naumann D
    Proteins; 1999 Feb; 34(3):303-16. PubMed ID: 10024018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anion binding and controlled aggregation of human interleukin-1 receptor antagonist.
    Raibekas AA; Bures EJ; Siska CC; Kohno T; Latypov RF; Kerwin BA
    Biochemistry; 2005 Jul; 44(29):9871-9. PubMed ID: 16026159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the pressure-induced intermediate and unfolded state of red-shifted green fluorescent protein--a static and kinetic FTIR, UV/VIS and fluorescence spectroscopy study.
    Herberhold H; Marchal S; Lange R; Scheyhing CH; Vogel RF; Winter R
    J Mol Biol; 2003 Jul; 330(5):1153-64. PubMed ID: 12860135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Denaturant-dependent conformational changes in a beta-trefoil protein: global and residue-specific aspects of an equilibrium denaturation process.
    Latypov RF; Liu D; Jacob J; Harvey TS; Bondarenko PV; Kleemann GR; Brems DN; Raibekas AA
    Biochemistry; 2009 Nov; 48(46):10934-47. PubMed ID: 19839644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of an active dimer during storage of interleukin-1 receptor antagonist in aqueous solution.
    Chang BS; Beauvais RM; Arakawa T; Narhi LO; Dong A; Aparisio DI; Carpenter JF
    Biophys J; 1996 Dec; 71(6):3399-406. PubMed ID: 8968609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of protein aggregation propensity with a melting point apparatus.
    Raibekas AA
    Anal Biochem; 2008 Sep; 380(2):331-2. PubMed ID: 18544334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of critical oligomers is a key event during conformational transition of recombinant syrian hamster prion protein.
    Sokolowski F; Modler AJ; Masuch R; Zirwer D; Baier M; Lutsch G; Moss DA; Gast K; Naumann D
    J Biol Chem; 2003 Oct; 278(42):40481-92. PubMed ID: 12917432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific volume and adiabatic compressibility measurements of native and aggregated recombinant human interleukin-1 receptor antagonist: density differences enable pressure-modulated refolding.
    Seefeldt MB; Crouch C; Kendrick B; Randolph TW
    Biotechnol Bioeng; 2007 Oct; 98(2):476-85. PubMed ID: 17335058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of fibril formation of bovine kappa-casein indicate a conformational rearrangement as a critical step in the process.
    Leonil J; Henry G; Jouanneau D; Delage MM; Forge V; Putaux JL
    J Mol Biol; 2008 Sep; 381(5):1267-80. PubMed ID: 18616951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-pressure studies of aggregation of recombinant human interleukin-1 receptor antagonist: thermodynamics, kinetics, and application to accelerated formulation studies.
    Seefeldt MB; Kim YS; Tolley KP; Seely J; Carpenter JF; Randolph TW
    Protein Sci; 2005 Sep; 14(9):2258-66. PubMed ID: 16081653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural characterization of the pressure-denatured state and unfolding/refolding kinetics of staphylococcal nuclease by synchrotron small-angle X-ray scattering and Fourier-transform infrared spectroscopy.
    Panick G; Malessa R; Winter R; Rapp G; Frye KJ; Royer CA
    J Mol Biol; 1998 Jan; 275(2):389-402. PubMed ID: 9466917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of benzyl alcohol on recombinant human interleukin-1 receptor antagonist structure and hydrogen-deuterium exchange.
    Alford JR; Fowler AC; Wuttke DS; Kerwin BA; Latypov RF; Carpenter JF; Randolph TW
    J Pharm Sci; 2011 Oct; 100(10):4215-24. PubMed ID: 21557223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.